Cite
HARVARD Citation
Mastrangelo, G. et al. (2018). Yellow fever vaccine 17D administered to healthy women aged between 40 and 54 years halves breast cancer risk. European journal of cancer prevention. 27 (4), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mastrangelo, G. et al. (2018). Yellow fever vaccine 17D administered to healthy women aged between 40 and 54 years halves breast cancer risk. European journal of cancer prevention. 27 (4), p. . [Online].